Paloma Partners Management CO Cara Therapeutics, Inc. Transaction History

Paloma Partners Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$9.12 - $17.78 $99,909 - $194,779	-10,955 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.11 - $25.98 $176,485 - $284,610	10,955 New	10,955 $176,000
Q1 2018 May 15, 2018	SELL	$11.77 - $16.08 $160,201 - $218,864	-13,611 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.86 - $14.08 $161,426 - $191,642	13,611	13,611 $167,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.